Quote | Super Quote
50797 UB#HSI RP2604R (R BEAR)
RT Nominal unchange0.345 0.000 (0.000%)

20/06/2024 15:13

{Hot Stocks}HANSOH PHARMA quoted at HK$16.44, down 5.1%

[ET Net News Agency, 20 June 2024] HANSOH PHARMA (03692) fell 5.1% to HK$16.44, dipping
below the 50-D SMA of HK$16.954.
It hits an intra-day low of HK$16.44, and an intra-day high of HK$17.28. The total
shares traded was 2.59 million, with a value of HK$43.28m. The active buy/sell ratio is
40:60, with net selling turnover of HK$7.98m. J.P. MORGAN BRO (HK) accounts for greatest
net responsive buying turnover of HK$3.01m, with volume weighted average price of
HK$16.693. UBS accounts for greatest net responsive selling turnover of HK$2.77m, with
volume weighted average price of HK$16.674.
The Hang Seng Index now fell 148 points, or 0.8% to 18,281.

Basic Information

Nominal 16.440 % Chg -5.08%
High 17.280 Low 16.440
Shares Tr 2.59m Turnover 43.28m
10-D SMA 17.336 %H.V 32.174
20-D SMA 16.950 VWAP 16.699
50-D SMA 16.954 RSI14 41.588
Status: Dipping below the 50-D SMA, active buy/sell ratio is 40:60, with net selling
turnover of HK$7.98m

Performance of stocks in the same sector or of relevance

Stock (Code) Price (HK$) Change (%)
HANSOH PHARMA (03692) 16.44 -5.08
ALI HEALTH (00241) 3.48 -2.52
TRAD CHI MED (00570) 4.24 Unchanged
CSPC PHARMA (01093) 6.40 -4.90
SINOPHARM (01099) 22.15 Unchanged
SINO BIOPHARM (01177) 2.70 -4.93
CHINARES PHARMA (03320) 5.93 -1.50
SCICLONE PHARMA (06600) 18.70 +0.75
JD HEALTH (06618) 23.55 -5.23
GOLDEN THROAT (06896) 3.29 +0.61

Remark: Real time quote last updated: 18/07/2024 09:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.